This information has been prepared by IG, a trading name of IG Australia Pty Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Perennial Real Estate Holdings, through its joint venture firm Perennial HC Holdings, has won the tender to develop two plots of land in Yunnan, China, at a land tender price of ¥341.5 million.
The plots of land are next to the Kunming South High Speed Railway (HSR), and the investment to the joint venture will be funded through equity capital calls from shareholders of the joint venture vehicle, Perennial said. The tender was awarded by the People’s Government of Chenggong District, Kunming.
The plots of land have 40-year commercial land use rights with a total land area of 65,054 square metres. Total maximum allowable gross floor area is 627,600 square metres. The integrated development will be developed into a regional healthcare and commercial hub that will comprise of medical care, eldercare, hospitality, meetings, incentives, conferences and exhibitions, and retail components.
Perennial owns a 45% stake in Perennial HC. The firm said in the statement that the tender aligns with the joint venture firm’s strategy to acquire, own and develop HSR healthcare and commercial integrated developments in Tier 1 or strong Tier 2 cities and provincial capitals in China with good connectivity to transportation hubs.
The firm added that the above transaction is not expected to have any material impact on the net tangible assets, or earnings per share of the company for the current financial year.
Perennial shares rose 0.83% or S$0.005 at S$0.60 minutes into trading on Thursday.
.jpg)
